WHO ICTRP trial
Evidence of the benefit of SYN-53 in the treatment of patients with allergic…
ISRCTN99056955 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN99056955 |
|---|---|
| Public title | Evidence of the benefit of SYN-53 in the treatment of patients with allergic rhinoconjunctivitis due to grass pollen and associated symptoms |
| Scientific title | Evidence of the benefit of SYN-53 in a double-blind, placebo-controlled monocentric study in the treatment of patients with allergic rhinoconjunctivitis due to grass pollen and associated symptoms |
| Primary sponsor | Synformulas GmbH |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Germany |
| Conditions | Allergic rhinoconjunctivitis caused by grass pollen Respiratory |
| Interventions | Treatment: 3 capsules (oral administration) of SYN-53 per day for 3 days after each exposure Control: 3 capsules of placebo (oral administration) per day for 3 days after each exposure Randomisation: 1:1 block randomisation by sealed… |
| Registration date | May 2, 2021 |
| Target size | 90 |
| Secondary IDs | Nil known;Nil known;Nil known |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: